A Phase 2, Randomized, Double-Blind Vehicle-Controlled Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2018
Price : $35 *
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Therapeutic Use
- Sponsors Dermira
- 05 Feb 2015 Results published in the Media Release.
- 18 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 05 Oct 2014 Planned End Date changed from 1 Oct 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov record.